MindImmune Appoints Industry Leaders to Board of Directors

Brad Margus and Robert Michael Poole, MD FACP, bring deep background and experience. Mr. Margus assumes role as Board Chair SOUTH KINGSTOWN, RI – January 3, 2024 – MindImmune Therapeutics, a pre-clinical stage biopharmaceutical company focused on neuroinflammation targeting Alzheimer’s disease as lead indication, today announced the appointments of Brad Margus and Robert Michael Poole, MD, FACP to […]

VoltServer secures $17.5M in Series B Funding

Innovative Energy Company VoltServer secures venture capital funding EAST GREENWICH, RI / ACCESSWIRE / April 19, 2023 / VoltServer™, the inventor of a new distribution format for electricity, announced today that it has raised $17.5 million Series B funding, led by Marker Hill Capital and Constellation Technology Ventures, followed by the Southwire Company, RightHill Ventures, and Clean Energy Venture Group. This brings the […]

RightHill Ventures Commits $1.5 Million to Slater-Backed Drug Discovery Company

New Fund Participates in Series A Financing for URI-Based MindImmune, Developer of a Novel Treatment for Neuroinflammatory Conditions Such as Alzheimer’s Disease PROVIDENCE, RI – June 21, 2022 –RightHill Ventures, dedicated to providing seed-stage capital and other startup support to university-based ventures, today announced that it has committed a total of $1.5 million in a financing round totaling […]

Noted Scientist Nancy Ryan Gray and Brown University Engineering Dean Lawrence Larson Join the Slater Board; Larson Named Chair

New Appointees Bring Critical Insight into the Commercialization of University-Based Research Providence, R.I. – March 8, 2022 – The Slater Technology Fund, Rhode Island’s oldest and most active seed-stage investment fund, today announced that Nancy Ryan Gray, Ph.D., president and CEO of the Gordon Research Conferences (GRC), and Lawrence Larson, Ph.D., who will be stepping […]